Point72 Hong Kong’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Point72 Hong Kong’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10,858	Closed	-$83K	–	2503
2022 Q1	$83K	Buy	+10,858	New	+$103K	﹤0.01%	1199
2021 Q4	–	Sell	-6,363	Closed	-$85K	–	2500
2021 Q3	$85K	Buy	+6,363	New	+$104K	﹤0.01%	1388
2021 Q1	–	Sell	-2,470	Closed	-$44K	–	2295
2020 Q4	$44K	Buy	2,470 +301	+14%	+$4.5K	﹤0.01%	1260
2020 Q3	$25K	Buy	+2,169	New	+$35.8K	﹤0.01%	826
2020 Q2	–	Sell	-38	Closed	–	–	1486
2020 Q1	$0	Buy	+38	New	+$710	﹤0.01%	1439
2019 Q2	–	Sell	-48	Closed	-$1K	–	1458
2019 Q1	$1K	Buy	+48	New	+$911	﹤0.01%	967
2018 Q4	–	Sell	-294	Closed	-$15K	–	1267
2018 Q3	$15K	Buy	+294	New	+$16K	0.01%	625

Other funds holding GTHX

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Hong Kong's GTHX Position: Q2 2022 in Review

Point72 Hong Kong sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q2 2022, closing a stake of 10,858 shares — an estimated $83K sold.

Point72 Hong Kong first reported a position in GTHX in Q3 2018 and held it in 7 quarters. The position peaked at $85K in Q3 2021. 98 funds tracked by Wall St. Rank hold GTHX as of Q2 2022.

Point72 Hong Kong reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Point72 Hong Kong sold 10,858 G1 Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $83K.
Point72 Hong Kong first reported a position in G1 Therapeutics, Inc. Common Stock in Q3 2018 and held it in 7 quarters.
Point72 Hong Kong's G1 Therapeutics, Inc. Common Stock position peaked at $85K in Q3 2021.
98 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Point72 Hong Kong's 13F filing for Q2 2022, filed 15 Aug 2022.